CD274 and melanoma: Apart from targeted therapy, the invigoration of antitumor immunity via the blockade of immune checkpoints like PD-1 or PD-L1 has also been ubiquitously employed in melanoma treatment since 10 years ago, which has unprecedentedly optimized tumor control.